Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
184 participants
OBSERVATIONAL
2024-09-01
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Brief Parent-based Sleep Intervention for Children With Autism Spectrum Disorder
NCT05010824
Effectiveness of Educational Program on Parenting Stress and Coping Mechanism Among Parents of Children With Autism Spectrum Disorder in Amman, Jordan
NCT03805828
Effectiveness of Mindfulness-Based Intervention in Reducing Stigma Stress Among Parents of Autistic Children
NCT06975163
Community-Engaged Sleep Intervention for School-Aged Children With Autism Spectrum Disorder
NCT07007819
Treatment of Sleep Disturbances in Young Children With Autism
NCT01322022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autistic parents
Parents who fulfill the main diagnosis of ASD, which includes atypical autism (ICD-10: F84.1) and Asperger syndrome (ICD-10: F84.5), who are ≥ 18 years old and have a child aged 0 to 6 years are included.
No interventions assigned to this group
Non-autistic parents
Parents are included who do not have a lifetime main diagnosis of a psychiatric illness (ICD-10-GM-2016: F10 - F69), who are ≥ 18 years old and have a child aged 0 to 6 years.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Have a child aged 0 to 6 years
* Parents without a lifetime main diagnosis of a psychiatric illness (ICD-10-GM-2016: F10 - F69)
* Age ≥ 18 years
* Have a child aged 0 to 6 years
* Matched to the study group in terms of age and gender
Exclusion Criteria
* Lack of German language skills
* Severe visual or hearing impairment (uncorrected)
* Serious neurological and psychiatric illnesses (e.g., epilepsy, psychoses)
* Acute suicidal tendencies (according to clinical findings)
Eligibility Criteria for the Control Group
* Above-mentioned psychiatric diagnoses
* Below-average general cognitive ability
* Lack of German language skills
* Severe impairment of vision or hearing (not corrected)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johannes Boettcher
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Hamburg-Eppendorf
Hamburg, City state of Hamburg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LPEK-0765
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.